Supriya Gupta

8PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersHaematological tumoursMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 30, 2026
Comparative survival and time toxicity outcomes of CAR-T versus bispecific antibody therapies in relapsed/refractory FL.

|Sep 19, 2026
Epidemiology and Survival Determinants of Monomorphic Epitheliotropic T-Cell Lymphoma: A Pooled Patient-Level Dataset Analysis.

|Mar 30, 2026
Management of hematological toxicities after BCMA-directed CAR-T cell therapy.

Joselle Cook, Supriya Gupta, Nadine Abdallah

|Oct 10, 2025
CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma: lessons learned from clinical trials and real world evidence.

Supriya Gupta, Veronika Bachanova

|Dec 27, 2024
Immune Checkpoint Inhibitor-Associated Celiac Disease: A Retrospective Analysis and Literature Review.

Malvika Gupta, Christopher Graham, Supriya Gupta

|Dec 17, 2023
Determinants of outcomes and advances in CD19-directed chimeric antigen receptor therapy for B-cell acute lymphoblastic leukemia.

Supriya Gupta, Mira Kohorst, Hassan B Alkhateeb

Pageof 2

Frequent Collaborators

3 joint publications

Christopher Graham

2 joint publications

Timothy J Voorhees

2 joint publications

John Sharp

1 joint publications

Mira Kohorst